• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从哨兵细胞到炎症罪魁祸首:肿瘤相关炎症中的肿瘤相关成纤维细胞。

From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation.

机构信息

Department of Pathology, Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel, 69978.

出版信息

J Pathol. 2013 Jan;229(2):198-207. doi: 10.1002/path.4103. Epub 2012 Nov 20.

DOI:10.1002/path.4103
PMID:22996812
Abstract

Inflammation is now established as a hallmark of cancer. Cancer-associated fibroblasts (CAFs) have been established as a key component of the crosstalk between tumour cells and their microenvironment. Central to the role of CAFs in facilitating tumour growth, invasion, and metastasis is their ability to orchestrate tumour-related inflammation. CAFs and their soluble mediators provide multiple complex regulatory signals that modulate the trafficking, differentiation status, and function of inflammatory cells in the tumour microenvironment. This review focuses on pathways by which CAFs mediate tumour-promoting inflammation and modify the components of the inflammatory microenvironment that facilitate tumour initiation, progression, and metastasis.

摘要

炎症现在被确定为癌症的一个标志。癌症相关成纤维细胞(CAFs)已被确定为肿瘤细胞与其微环境之间相互作用的关键组成部分。CAFs 在促进肿瘤生长、侵袭和转移中的作用的核心是它们协调肿瘤相关炎症的能力。CAFs 及其可溶性介质提供了多种复杂的调节信号,调节肿瘤微环境中炎症细胞的迁移、分化状态和功能。本文综述了 CAFs 介导肿瘤促进炎症的途径,并修饰了促进肿瘤起始、进展和转移的炎症微环境成分。

相似文献

1
From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation.从哨兵细胞到炎症罪魁祸首:肿瘤相关炎症中的肿瘤相关成纤维细胞。
J Pathol. 2013 Jan;229(2):198-207. doi: 10.1002/path.4103. Epub 2012 Nov 20.
2
An inflammatory vicious cycle: Fibroblasts and immune cell recruitment in cancer.一种炎症恶性循环:癌症中的成纤维细胞与免疫细胞募集
Exp Cell Res. 2013 Jul 1;319(11):1596-603. doi: 10.1016/j.yexcr.2013.03.022. Epub 2013 Apr 5.
3
Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors.癌症相关成纤维细胞在人类乳腺和卵巢肿瘤中表达促炎因子。
Biochem Biophys Res Commun. 2013 Aug 2;437(3):397-402. doi: 10.1016/j.bbrc.2013.06.089. Epub 2013 Jul 2.
4
Inflammatory fibroblasts in cancer.癌症中的炎症成纤维细胞。
Arch Pharm Res. 2016 Aug;39(8):1021-31. doi: 10.1007/s12272-016-0787-8. Epub 2016 Jul 6.
5
Regulation of the anti-tumour immune response by cancer-associated fibroblasts.肿瘤相关成纤维细胞对肿瘤免疫应答的调控。
Semin Cancer Biol. 2014 Apr;25:69-77. doi: 10.1016/j.semcancer.2013.12.005. Epub 2014 Jan 7.
6
More than structural cells, fibroblasts create and orchestrate the tumor microenvironment.成纤维细胞不仅仅是结构细胞,它们还构建并调控肿瘤微环境。
Immunol Invest. 2006;35(3-4):297-325. doi: 10.1080/08820130600754960.
7
Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.癌相关成纤维细胞在早期肿瘤发生时被激活,以 NF-κB 依赖的方式协调促进肿瘤的炎症反应。
Cancer Cell. 2010 Feb 17;17(2):135-47. doi: 10.1016/j.ccr.2009.12.041. Epub 2010 Feb 4.
8
The fundamental role of mechanical properties in the progression of cancer disease and inflammation.机械性能在癌症疾病和炎症进展中的基本作用。
Rep Prog Phys. 2014 Jul;77(7):076602. doi: 10.1088/0034-4885/77/7/076602. Epub 2014 Jul 9.
9
Inflammation-mediated promotion of invasion and metastasis.炎症介导促进侵袭和转移。
Cancer Metastasis Rev. 2010 Jun;29(2):243-8. doi: 10.1007/s10555-010-9227-2.
10
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression.癌相关成纤维细胞和肿瘤细胞:驱动癌症进展的恶性循环。
Cancer Metastasis Rev. 2012 Jun;31(1-2):195-208. doi: 10.1007/s10555-011-9340-x.

引用本文的文献

1
Crosstalk between cancer‑associated fibroblasts and inflammation in tumor microenvironment: A novel perspective in cancer therapy (Review).肿瘤微环境中癌症相关成纤维细胞与炎症之间的相互作用:癌症治疗的新视角(综述)
Oncol Rep. 2025 Aug;54(2). doi: 10.3892/or.2025.8926. Epub 2025 Jun 13.
2
Nano-drug delivery strategies affecting cancer-associated fibroblasts to reduce tumor metastasis.影响癌症相关成纤维细胞以减少肿瘤转移的纳米药物递送策略。
Acta Pharm Sin B. 2025 Apr;15(4):1841-1868. doi: 10.1016/j.apsb.2025.02.040. Epub 2025 Mar 8.
3
4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models.
靶向成纤维细胞活化蛋白α的4-1BB激动剂与放疗协同作用治疗小鼠乳腺肿瘤模型。
J Immunother Cancer. 2025 Feb 11;13(2):e009852. doi: 10.1136/jitc-2024-009852.
4
Cancer-Associated-Fibroblast-Mediated Paracrine and Autocrine SDF-1/CXCR4 Signaling Promotes Stemness and Aggressiveness of Colorectal Cancers.肿瘤相关成纤维细胞介导的旁分泌和自分泌 SDF-1/CXCR4 信号促进结直肠癌细胞的干性和侵袭性。
Cells. 2024 Aug 12;13(16):1334. doi: 10.3390/cells13161334.
5
KMT2A and chronic inflammation as potential drivers of sporadic parathyroid adenoma.KMT2A 和慢性炎症作为散发甲状旁腺腺瘤的潜在驱动因素。
Clin Transl Med. 2024 Jun;14(6):e1734. doi: 10.1002/ctm2.1734.
6
The prognostic value of preoperative peripheral blood inflammatory indicators for squamous cell carcinoma of tongue.术前外周血炎症指标对舌鳞状细胞癌的预后价值
Hua Xi Kou Qiang Yi Xue Za Zhi. 2022 May 25;40(3):335-340. doi: 10.7518/hxkq.2022.03.014.
7
Unraveling the Role of Ras Homolog Enriched in Brain (Rheb1 and Rheb2): Bridging Neuronal Dynamics and Cancer Pathogenesis through Mechanistic Target of Rapamycin Signaling.解析大脑中富含 Ras 的同系物(Rheb1 和 Rheb2)的作用:通过雷帕霉素靶蛋白信号传导连接神经元动力学和癌症发病机制。
Int J Mol Sci. 2024 Jan 25;25(3):1489. doi: 10.3390/ijms25031489.
8
The Role of the Tumor Microenvironment in Triple-Positive Breast Cancer Progression and Therapeutic Resistance.肿瘤微环境在三阳性乳腺癌进展和治疗耐药中的作用
Cancers (Basel). 2023 Nov 20;15(22):5493. doi: 10.3390/cancers15225493.
9
Colitis-associated carcinogenesis: crosstalk between tumors, immune cells and gut microbiota.结肠炎相关的致癌作用:肿瘤、免疫细胞与肠道微生物群之间的相互作用
Cell Biosci. 2023 Oct 24;13(1):194. doi: 10.1186/s13578-023-01139-8.
10
A new approach to overcoming resistance to immunotherapy: nanotechnology.一种克服免疫疗法耐药性的新方法:纳米技术。
Front Oncol. 2023 Aug 10;13:1210245. doi: 10.3389/fonc.2023.1210245. eCollection 2023.